Citations

Mayo Clinic

Showing 10 of 108599 citations.

Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Shah, Bijal , Cassaday, Ryan D. , Park, Jae H. , Oluwole, Olalekan O. , Leguay, Thibaut , Bishop, Michael R. , Topp, Max S. , Tzachanis, Dimitrios , O’Dwyer, Kristen M. , Arellano, Martha , Baer, Maria R. , Schiller, Gary J. , Abedi, Mehrdad , Stiff, Patrick J. , Jeyakumar, Deepa , Mao, Daqin , Adhikary, Sabina , Zhou, Lang, Schuberth, Petra, Khalid, Rita Damico, Ghobadia, Armin, Shah, Bijal , Oluwole, Olalekan O , Cassaday, Ryan D , Houot, Roch , Logan, Aaron C , Boissel, Nicolas , Bishop, Michael Russell , O'Dwyer, Kristin , Lin, Yi , Subklewe, Marion , Minnema, Monique C , Wierda, William G. , DeAngelo, Daniel J.

Journal for ImmunoTherapy of Cancer | August 30, 2023 | Volume: 11 | Issue: 8 | Pages: e007118

10.1136/jitc-2023-007118 | PMID 37648261 Get It

Background Brexucabtagene autoleucel (brexu-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved in the USA for adults with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and in the European Union for patients ≥26 years with R/R B-ALL. After 2 years of follow-up in ZUMA-3, the overall complete remission (CR) rate (CR+CR with incomplete hematological recovery (CRi)) was 73%, and the median overall survival (OS) was 25.4 months in 78 Phase 1 and 2 patients with R/R B-ALL who received the pivotal dose of brexu-cel. Outcomes by prior therapies and subsequent allogeneic stem cell transplantation (alloSCT) are reported. Methods Eligible adults had R/R B-ALL and received one infusion of brexu-cel (1×10⁶ CAR T cells/kg) following conditioning chemotherapy. The primary endpoint was the CR/CRi rate per central review. Post hoc subgroup analyses were exploratory with descriptive statistics provided. Results Phase 1 and 2 patients (N=78) were included with median follow-up of 29.7 months (range, 20.7–58.3). High CR/CRi rates were observed across all prior therapy subgroups examined: 1 prior line of therapy (87%, n=15) and ≥2 prior lines (70%, n=63); prior blinatumomab (63%, n=38) and no prior blinatumomab (83%, n=40); prior inotuzumab (59%, n=17) and no prior inotuzumab (77%, n=61); and prior alloSCT (76%, n=29) and no prior alloSCT (71%, n=49). The frequency of Grade ≥3 cytokine release syndrome, neurological events, and treatment-related Grade 5 adverse events were largely similar among prior therapy subgroups. Median duration of remission (DOR) in responders with (n=14) and without (n=43) subsequent alloSCT was 44.2 (95% CI, 8.1 to not estimable (NE)) and 18.6 months (95% CI, 9.4 to NE); median OS was 47.0 months (95% CI, 10.2 to NE) and not reached (95% CI, 23.2 to NE), respectively. Median DOR and OS were not reached in responders without prior or subsequent alloSCT (n=22). Conclusions In ZUMA-3, adults with R/R B-ALL benefited from brexu-cel, regardless of prior therapies and subsequent alloSCT status, though survival appeared better in patients without certain prior therapies and in earlier lines of therapy. Additional studies are needed to determine the impact prior therapies and subsequent alloSCT have on outcomes of patients who receive brexu-cel.
Introduction to concept inventories for medical physics education
Cetnar, Ashley J. , Besemer, Abby, Bry, Victoria, Buckey, C, Burmeister, Jay , Rodrigues, Anna , Schubert, Leah , Speidel, Michael A. , Sutlief, Steven , Yu, Amy S. , Buckey, Courtney R, Yu, Amy Shu-Jung , Bry, Victoria N.

Journal of Applied Clinical Medical Physics | August 30, 2023 | Volume: 24 | Issue: 10 | Pages: No page available

10.1002/acm2.14130 | PMID 37646429 Get It

AbstractConcept inventories are multiple choice exams designed with the intention to test core concepts on specific subjects and evaluate common misconceptions. These tests serve as a useful tool in the classroom to assess value added by the instructor's educational methods and to better understand how students learn. They can provide educators with a method to evaluate their current teaching strategies and to make modifications that enhance student learning and ultimately elevate the quality of medical physics education. The use of concept inventories in introductory college physics courses revealed important gaps in conceptual understanding of physics by undergraduate students and motivated a shift of physics teaching towards more effective methods, such as active learning techniques. The goal of this review is to introduce medical physicists to concept inventories as educational evaluation tools and discuss potential applications to medical physics education by development through multi‐institutional collaboration.
Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies
Fleseriu, Cara M. , Beswick, Daniel M. , Maoz, Sabrina L. , Hwang, Peter H. , Chan, Erik, Adappa, Nithin D. , Getz, Anne E., Humphries, Ian M., Chang, Eugene H. , Jafari, Aria , Kingdom, Todd T. , Kohanski, Michael A. , Lee, Jivianne K., Nabavizadeh, Seyed Ali , Adappa, Nithin D. , Patel, Zara M. , Smith, Timothy L. , Storm, Jay, Wang, Marilene B. , Choby, Garret , Kuan, Edward C , Humphreys, Ian M , Jafari, Aria , Nayak, Jayakar V , Patel, Zara , Smith, Timothy L , Snyderman, Carl H , Wang, Eric W , Beswick, Daniel , Hwang, Peter H , Maoz, Sabrina L , Choby, Garret , Adappa, Nithin D. , Geltzeiler, Mathew , Humphreys, Ian M. , Le, Christopher H. , Abuzeid, Waleed M. , Lee, Jivianne K., Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Resnick, Adam , John, Maie A. St. , Suh, Jeffrey D.

International Forum of Allergy & Rhinology | August 30, 2023 | Volume: 14 | Issue: 4 | Pages: 775-785

10.1002/alr.23261 | PMID 37646428 Get It

AbstractBackgroundThe impact of sinonasal malignancies (SNMs) on quality of life (QOL) at presentation is poorly understood. The Sinonasal Outcome Test (SNOT‐22) and University of Washington Quality of Life (UWQOL) are validated QOL instruments with distinctive subdomains. This study aims to identify factors impacting pretreatment QOL in SNM patients to personalize multidisciplinary management and counseling.MethodsPatients with previously untreated SNMs were prospectively enrolled (2015–2022) in a multicenter observational study. Baseline pretreatment QOL instruments (SNOT‐22, UWQOL) were obtained along with demographics, comorbidities, histopathology/staging, tumor involvement, and symptoms. Multivariable regression models identified factors associated with reduced baseline QOL.ResultsAmong 204 patients, presenting baseline QOL was significantly reduced. Multivariable regression showed worse total SNOT‐22 QOL in patients with skull base erosion (p = 0.02). SNOT‐rhinologic QOL was worse in women (p = 0.009), patients with epistaxis (p = 0.036), and industrial exposure (p = 0.005). SNOT extranasal QOL was worse in patients with industrial exposure (p = 0.016); worse SNOT ear/facial QOL if perineural invasion (PNI) (p = 0.027). Squamous cell carcinoma pathology (p = 0.037), palate involvement (p = 0.012), and pain (p = 0.017) were associated with worse SNOT sleep QOL scores. SNOT psychological subdomain scores were significantly worse in patients with palate lesions (p = 0.022), skull base erosion (p = 0.025), and T1 staging (p = 0.023). Low QOL was more likely in the presence of PNI on UW health (p = 0.019) and orbital erosion on UW overall (p = 0.03). UW social QOL was worse if palatal involvement (p = 0.023) or PNI (p = 0.005).ConclusionsOur findings demonstrate a negative impact on baseline QOL in patients with SNMs and suggest sex‐specific and symptom‐related lower QOL scores, with minimal histopathology association. Anatomical tumor involvement may be more reflective of QOL than T‐staging, as orbital and skull base erosion, PNI, and palate lesions are significantly associated with reduced baseline QOL.
Minimally Invasive Surgery Debate for Myomectomy: Conventional or Robotic-Assisted Laparoscopy
Duncan, Jordann-Mishael, Brown, Samantha , Ranieri, Gina , Brown, Samantha J , Wasson, Megan

Journal of Gynecologic Surgery | August 30, 2023 | Volume: 40 | Issue: 1 | Pages: 14-16

10.1089/gyn.2023.0059 Get It

Predictors of morbidity and in‐hospital mortality following procedure‐related cardiac tamponade
Deshpande, Saurabh , Swatari, Hiroyuki, Ahmed, Raheel , Collins, George , Padmanabhan, Deepak , Sawatari, Hiroyuki , Ahmed, Raheel , Deshpande, Saurabh , Khanji, Mohammed Y , Somers, Virend K. , Chahal, C. Anwar A.

Journal of Arrhythmia | August 30, 2023 | Volume: 39 | Issue: 5 | Pages: 790-798

10.1002/joa3.12911 | PMID 37799802 Get It

AbstractBackgroundCardiac tamponade (CT) can be a complication following invasive cardiac procedures. We assessed CT following common cardiac electrophysiology (EP) procedures to facilitate risk prediction of associated morbidity and in‐hospital mortality.MethodsPatients who underwent various EP procedures in the cardiac catheterization lab (ablations and device implantations) were identified using the International Classification of Diseases, Ninth and Tenth Edition, Clinical Modification (ICD‐9‐CM and ICD‐10‐CM, respectively) from the Nationwide Inpatient Sample (NIS) database. Patient demographics, presence of comorbidities, CT‐related events, and in‐hospital death were also abstracted from the NIS database.ResultsThe frequency of CT‐related events in patients with EP intervention from 2010 to 2017 ranged from 3.4% to 7.0%. In‐hospital mortality related to CT‐related events was found to be 2.2%. Increasing age was the only predictor of higher mortality in atrial fibrillation (AF) ablation and cardiac resynchronization therapy (CRT) groups (OR [95% CI]: AF ablation = 11.15 [1.70–73.34], p = .01; CRT = 1.41 [1.05–1.90], p = .02).ConclusionsIn the real‐world setting, CT‐related events in EP procedures were found to be 3.4%–7.0% with in‐hospital mortality of 2.2%. Older patients undergoing AF ablation were found to have higher mortality.
Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury
Pareja, Jennifer C. Muñoz , Vaccari, Juan Pablo de Rivero , Chavez, Maria Mateo , Kerrigan, Maria, Pringle, Charlene , Guthrie, Kourtney, Swaby, Kathryn, Coto, Jennifer , Avery, K. Leslie , Ghosh, Suman , Dhanashree, Rajderkar, Shanmugham, Prashanth, Lautenslager, Lauren A. , Faulkenberry, Shannon, Zabala, María C. Pareja , Fakhri, Nora Al, Loor-Torres, Ricardo , Governale, Lance S., Blatt, Jason E. , Gober, Joslyn , Perez, Paula Karina, O’Phelan, Kristine , Dietrich, W. Dalton , Mateo Chavez, Maria B , Pringle, Charlene P , de Rivero Vaccari, Juan Pablo , Kobeissy, Firas , Solano, Juan, McCrea, Heather J. , Thorson, Chad M. , Keane, Robert W. , Wang, Kevin

Journal of Neurotrauma | August 30, 2023 | Volume: 41 | Issue: 1-2 | Pages: 106-122

10.1089/neu.2023.0039 | PMID 37646421 Get It

Traumatic brain injury (TBI) remains a major cause of morbidity and death among the pediatric population. Timely diagnosis, however, remains a complex task because of the lack of standardized methods that permit its accurate identification. The aim of this study was to determine whether serum levels of brain injury biomarkers can be used as a diagnostic and prognostic tool in this pathology. This prospective, observational study collected and analyzed the serum concentration of neuronal injury biomarkers at enrollment, 24h and 48h post-injury, in 34 children ages 0–18 with pTBI and 19 healthy controls (HC). Biomarkers included glial fibrillary acidic protein (GFAP), neurofilament protein L (NfL), ubiquitin-C-terminal hydrolase (UCH-L1), S-100B, tau and tau phosphorylated at threonine 181 (p-tau181). Subjects were stratified by admission Glasgow Coma Scale score into two categories: a combined mild/moderate (GCS 9–15) and severe (GCS 3–8). Glasgow Outcome Scale-Extended (GOS-E) Peds was dichotomized into favorable (≤4) and unfavorable (≥5) and outcomes. Data were analyzed utilizing Prism 9 and R statistical software. The findings were as follows: 15 patients were stratified as severe TBI and 19 as mild/moderate per GCS. All biomarkers measured at enrollment were elevated compared with HC. Serum levels for all biomarkers were significantly higher in the severe TBI group compared with HC at 0, 24, and 48h. The GFAP, tau S100B, and p-tau181 had the ability to differentiate TBI severity in the mild/moderate group when measured at 0h post-injury. Tau serum levels were increased in the mild/moderate group at 24h. In addition, NfL and p-tau181 showed increased serum levels at 48h in the aforementioned GCS category. Individual biomarker performance on predicting unfavorable outcomes was measured at 0, 24, and 48h across different GOS-E Peds time points, which was significant for p-tau181 at 0h at all time points, UCH-L1 at 0h at 6–9 months and 12 months, GFAP at 48h at 12 months, NfL at 0h at 12 months, tau at 0h at 12 months and S100B at 0h at 12 months. We concluded that TBI leads to increased serum neuronal injury biomarkers during the first 0–48h post-injury. A biomarker panel measuring these proteins could aid in the early diagnosis of mild to moderate pTBI and may predict neurological outcomes across the injury spectrum.
Rising incidence and impact of early‐onset colorectal cancer in the Asia‐Pacific with higher mortality in females from Southeast Asia: a global burden analysis from 2010 to 2019
Danpanichkul, Pojsakorn , Moolkaew, Pinyada , Kanjanakot, Yatawee , Jaroenlapnopparat, Aunchalee , Kim, Donghee , Lukens, Frank , Wassef, Wahid , Fallon, Michael B. , Chen, Vincent , Lukens, Frank J., Lui, Rashid , Wijarnpreecha, Karn , Chen, V L , Kim, Donghee , Danpanichkul, Pojsakorn , Polpichai, Natchaya , Wijarnpreecha, Karn

Journal of Gastroenterology and Hepatology | August 30, 2023 | Volume: 38 | Issue: 12 | Pages: 2053-2060

10.1111/jgh.16331 | PMID 37644698 Get It

AbstractBackground and AimEarly‐onset colorectal cancer (CRC) is a growing global health concern, especially in the Asia‐Pacific region. However, comprehensive research on this topic from the region is lacking. Our study aims to investigate trends in early‐onset CRC in Asia over 10 years, filling this research gap.MethodsThis study utilized data from the Global Burden of Disease Study 2019 to assess temporal trends in early‐onset CRC in the Asia‐Pacific. The analysis included estimating annual frequencies and age‐standardized rates (ASRs) of early‐onset CRC incidence, death, and disability‐adjusted life‐years (DALYs) by gender.ResultsThe incidence of early‐onset CRC significantly increased in both regions with higher increase and in the Western Pacific region. Notable increases were observed among males in the Western Pacific and females in Southeast Asia (SEA). Mortality rates remained stable in the Western Pacific but increased by 10.6% in SEA, especially among females. DALYs due to CRC also increased significantly in SEA, with a greater rise among females. The Western Pacific had the highest CRC incidence, and in SEA, the mortality rate was higher in females than males.ConclusionsOur study reveals a substantial increase in early‐onset CRC in the Asia‐Pacific underscoring the urgency for effective interventions. Thus, a comprehensive approach comprising controlled risk reduction, health promotion to heightened disease awareness, and implementation of effective screening strategies should be executed timely to mitigate the burden of early‐onset CRC.
Application of Innovative Subject Recruitment System for Batch Enrollment: A Pilot Study
Wi, Chung‐Il , Ryu, Euijung , Natoli, Traci L., Miller, Ryan P, Spiten, Matthew J., Pignolo, Robert J. , Juhn, Young J. , King, Katherine S. , Takahashi, Paul Y. , Juhn, Y J , Wi, Chung-Ii , Miller, Ryan P., Borah, Bijan J. , Yao, Xiaoxi , Noseworthy, Peter A.

Journal of Primary Care & Community Health | August 30, 2023 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/21501319231194967 | PMID 37646152 Get It

Introduction: Using a digital process that leverages electronic health records (EHRs) can ease many of the challenges presented by the traditional enrollment process for clinical trials. We tested if automated batch enrollment using a technology-enabled subject recruitment system (TESRS) enhances recruitment while preserving representation of research subjects for the study population in our study setting. Methods: An ongoing community-based prospective adult cohort study was used to randomize 600 subjects who were eligible by age and residential address to TESRS (n = 300) and standard mailing method (n = 300), respectively, for 3 months. Then, TESRS was initiated and included automatic identification of patients’ preference for being contacted (online patient portal vs postal mail) from EHRs and automatic sending out of invitation letters followed by completion of a short online survey for checking eligibility and the digital consent process if eligible. We compared (1) median time to consent from invitation sent out per subject and total subjects recruited after a 3-month recruitment period, (2) the estimated study staff’s time, and (3) representation of sociodemographic characteristics (e.g., age, sex, race, SES measured by HOUSES index, and rural residence) between subjects recruited via TESRS and those via traditional mailing methods. Results: Median age of randomized subjects (n = 600) was 63 years with 52.0% female and 89.2% non-Hispanic White. Over a 3-month period, results showed consent rate via TESRS was 13% (39/297) similar to 11% (31/295) via standard mailing. However, recruitment was significantly faster with the TESRS approach (median 7 vs 26 days) given the study staff’s effort. Study staff’s time saved by using TESRS compared to standard mailing approach was estimated at 40 min per subject (equivalent to 200 h for 300 subjects). No significant differences in characteristics of research subjects from the study population were found. Conclusion: Our study demonstrated the utility of TESRS as a subject recruitment digital technology which significantly enhanced the recruitment effort while reducing the study staff burden of recruitment while maintaining the consistency of characteristics of recruited subjects. The strategy and support for implementing and testing TESRS in other study settings should be considered.
A review of acute ischemic stroke caused by distal, medium vessel occlusions
Kobeissi, Hassan , Bilgin, Cem , Ghozy, Sherief , Kadirvel, Ramanathan , Kallmes, David F. , Brinjikji, Waleed , Ghozy, Sherief , Kobeissi, Hassan , Bilgin, Cem

Interventional Neuroradiology | August 30, 2023 | Volume: 31 | Issue: 6 | Pages: 846-851

10.1177/15910199231197616 | PMID 37644821 Get It

Acute ischemic stroke (AIS) due to distal, medium vessel occlusion (DMVO) is increasingly recognized as the next frontier for mechanical thrombectomy. Distal, medium vessel occlusions are typically defined as an occlusion in the following arteries: anterior cerebral artery, M2–M4 segments of the middle cerebral artery, posterior cerebral artery, posterior inferior cerebellar artery, anterior inferior cerebellar artery, and superior cerebellar artery. It is estimated that 25–40% of all AIS is due to DMVO. Because of the large burden of DMVO, the frequency of literature published regarding these occlusions has greatly increased in recent years. Furthermore, treatment modalities have been created specifically for DMVOs. Due to the rapidly evolving literature on this topic, remaining up to date on DMVO definitions, anatomy, management, imaging, and clinical course is difficult. In this review article, we synthesized existing literature regarding the aforementioned topics and discussed future directions.
Delivering dimensional diagnoses: 3D echocardiography in heart transplantation
Fritz, Ashley Virginia , Allen, Wesley L. , Allen, Wesley, Martin, Archer Kilbourne , Pham, Si M.

European Heart Journal - Cardiovascular Imaging | August 30, 2023 | Volume: 24 | Issue: 11 | Pages: e299-e299

10.1093/ehjci/jead220 | PMID 37643917 Get It